Insiders · Profile

Quart Barry D

Director at Kiniksa Pharmaceuticals International · Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/. Filing since 20 Nov 2013. CIK 0001384243

KNSA Kiniksa Pharmaceuticals International, plc Director · 12 trades HRTX HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer · 7 trades

Company

Date

Role

Action

Shares

Amount

Of holding

KNSA Kiniksa Pharmaceuticals International, plc

28 Apr 2026

Director

Sold on a plan

13,099

$656.26K

51.1%

KNSA Kiniksa Pharmaceuticals International, plc

6 Apr 2026

Director

Sold on a plan

6,901

$345.05K

35.5%

KNSA Kiniksa Pharmaceuticals International, plc

12 Feb 2026

Director

Sold on a plan

2,690

$121.05K

17.7%

KNSA Kiniksa Pharmaceuticals International, plc

10 Feb 2026

Director

Sold on a plan

110

$4.95K

0.9%

KNSA Kiniksa Pharmaceuticals International, plc

4 Feb 2026

Director

Sold on a plan

2,602

$117.14K

17.2%

KNSA Kiniksa Pharmaceuticals International, plc

3 Feb 2026

Director

Sold on a plan

12,528

$567.14K

50.0%

KNSA Kiniksa Pharmaceuticals International, plc

2 Feb 2026

Director

Sold on a plan

830

$37.35K

6.2%

KNSA Kiniksa Pharmaceuticals International, plc

15 Dec 2025

Director

Sold on a plan

20,129

$835.55K

61.6%

KNSA Kiniksa Pharmaceuticals International, plc

11 Jun 2025

Director

Sold at will

12,336

$374.89K

49.6%

KNSA Kiniksa Pharmaceuticals International, plc

10 Jun 2025

Director

Sold at will

8,212

$249.32K

39.6%

KNSA Kiniksa Pharmaceuticals International, plc

9 Jun 2025

Director

Sold at will

6,900

$208.79K

35.5%

KNSA Kiniksa Pharmaceuticals International, plc

29 Nov 2022

Director

Sold, plan not stated

21,959

$354.64K

100%

HRTX HERON THERAPEUTICS, INC. /DE/

3 Oct 2019

Chief Executive Officer

Bought

4,571

$79.99K

5.1%

HRTX HERON THERAPEUTICS, INC. /DE/

21 Jun 2018

Chief Executive Officer

Sold, plan not stated

50,000

$1.95M

41.8%

HRTX HERON THERAPEUTICS, INC. /DE/

19 Mar 2018

Chief Executive Officer

Sold, plan not stated

100,000

$2.98M

59.5%

HRTX HERON THERAPEUTICS, INC. /DE/

14 Mar 2018

Chief Executive Officer

Sold, plan not stated

100,000

$2.48M

59.5%

HRTX HERON THERAPEUTICS, INC. /DE/

2 Mar 2015

Chief Executive Officer

Sold, plan not stated

10,000

$130.73K

18.9%

HRTX HERON THERAPEUTICS, INC. /DE/

25 Jun 2014

Chief Executive Officer

Bought

10,000

$117.50K

19.3%

HRTX HERON THERAPEUTICS, INC. /DE/

20 Nov 2013

Chief Executive Officer

Bought

1,000,000

$400.00K

×27

19 decisions on file.